These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6722990)

  • 21. Characterization of rat lung epoxide (styrene oxide) hydrase with a modified radioactive assay of improved sensitivity.
    Seidegård J; DePierre JW; Moron MS; Johannesen KA; Ernster L
    Cancer Res; 1977 Apr; 37(4):1075-82. PubMed ID: 402999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships of quantum mechanical calculations, relative mutagenicity of benzo[a]anthracene diol epoxides, and "bay region" concept of aromatic hydrocarbon carcinogenicity.
    Lehr RE; Jerina DM
    J Toxicol Environ Health; 1977 Jul; 2(6):1259-65. PubMed ID: 328916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of dihydrodiols and diol epoxides of dibenz[a, h]acridine in bacterial and mammalian cells.
    Wood AW; Chang RL; Katz M; Conney AH; Jerina DM; Sikka HC; Levin W; Kumar S
    Cancer Res; 1989 Dec; 49(24 Pt 1):6981-4. PubMed ID: 2684405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis.
    Hecht SS; Amin S; Huie K; Melikian AA; Harvey RG
    Cancer Res; 1987 Oct; 47(20):5310-5. PubMed ID: 3652037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotoxicity and carcinogenicity of glycidyl ethers.
    Hopkins J
    Food Chem Toxicol; 1984 Sep; 22(9):780-3. PubMed ID: 6386633
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural characteristics of compounds that can be activated to chemically reactive metabolites: use for a prediction of a carcinogenic potential.
    Lutz WK
    Arch Toxicol Suppl; 1984; 7():194-207. PubMed ID: 6595983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary metabolism of epoxides.
    Smith BR; Maguire JH; Ball LM; Bend JR
    Fed Proc; 1978 Sep; 37(11):2480-4. PubMed ID: 357180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A free energy approach to the prediction of olefin and epoxide mutagenicity and carcinogenicity.
    Kostal J; Voutchkova-Kostal A; Weeks B; Zimmerman JB; Anastas PT
    Chem Res Toxicol; 2012 Dec; 25(12):2780-7. PubMed ID: 23106682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.
    Kapitulnik J; Wislocki PG; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Feb; 38(2):354-8. PubMed ID: 620406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure--mutagenicity relationships for chlorinated ethylenes: a model based on the stability of the metabolically derived epoxides.
    Jones RB; Mackrodt WC
    Biochem Pharmacol; 1982 Nov; 31(22):3710-2. PubMed ID: 7181961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential carcinogenic and mutagenic industrial chemicals. I. Alkylating agents.
    Fishbein L
    J Toxicol Environ Health; 1980; 6(5-6):1133-77. PubMed ID: 7007656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Halogenated olefins and their epoxides: factors underlying carcinogenic activity.
    Politzer P; Laurence PR; Jayasuriya K
    Prog Clin Biol Res; 1985; 172A():227-37. PubMed ID: 3991672
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons.
    Sayer JM; Whalen DL; Jerina DM
    Drug Metab Rev; 1989; 20(2-4):155-82. PubMed ID: 2680377
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic transformation of clinically used drugs to epoxides: new perspectives in drug-drug interactions.
    Oesch F
    Biochem Pharmacol; 1976 Sep; 25(17):1935-7. PubMed ID: 985529
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
    Luo G; Qato MK; Guenthner TM
    Drug Metab Dispos; 1992; 20(3):440-5. PubMed ID: 1521503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Styrene, styrene oxide, polystyrene, and beta-nitrostyrene/styrene carcinogenicity in rodents.
    Huff JE
    Prog Clin Biol Res; 1984; 141():227-38. PubMed ID: 6718375
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of liver microsomal mono-oxygenases on some epoxide-forming cyclic tricyclic drugs. I. Kinetics in vitro.
    Pachecka J; Salmona M; Cantoni L; Mussini E; Pantarotto C; Frigerio A; Belvedere G
    Xenobiotica; 1976 Oct; 6(10):593-8. PubMed ID: 983116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 39. Diepoxybutane.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 11():115-23. PubMed ID: 791811
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats.
    Amin S; Lin JM; Krzeminski J; Boyiri T; Desai D; El-Bayoumy K
    Chem Res Toxicol; 2003 Feb; 16(2):227-31. PubMed ID: 12588194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.